Fintepla
Payments companies reported to CMS as associated with Fintepla. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fintepla, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fintepla
These are the largest totals companies reported as associated with Fintepla. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Selim Benbadis | Tampa, FL | Neurology (Psychiatry & Neurology) | $281,598.87 |
| Raman Sankar | Los Angeles, CA | Neurodevelopmental Disabilities (Pediatrics) | $272,064.68 |
| James Wheless | Memphis, TN | Neurology With Special Qualifications In Child Neurology | $141,822.84 |
| David Burdette | Grand Rapids, MI | Epilepsy | $132,150.07 |
| Robert Wechsler | Boise, ID | Clinical Neurophysiology | $112,527.40 |
| Jesus Pina Garza | Nashville, TN | Neurology With Special Qualifications In Child Neurology | $109,494.63 |
| Micheal Macken | Chicago, IL | Clinical Neurophysiology | $105,412.02 |
| Atiya Khan | Fort Wayne, IN | Neurology With Special Qualifications In Child Neurology | $104,510.35 |
| Heidi Henninger | Scarborough, ME | Neurology (Psychiatry & Neurology) | $82,209.89 |
| Karen Keough | Austin, TX | Epilepsy | $70,455.99 |
Prescribed Fintepla?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.